SEC Form 4 · accession 0001144204-18-049518
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Schrepfer
Officer — SVP - New Bus Dev & Spec Sales
Period of report
Sep 11, 2018
Accepted (ET)
Sep 14, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2018 | M | 28,688 | $6.60 | A | 47,842 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1 | $6.60 | Sep 11, 2018 | M | 28,688 | D | — | Jul 31, 2023 | Common Stock | 26,688 | 0 | D |
Explanation of responses
- F1Option vests over a four year period beginning on the first anniversary of August 1, 2013.